Novartis & Incyte Set To Roll Jakafi – JAK Inhibitor Into COVID-19 Clinical Trial
Posted by
www.biotecnika.org
Novartis and Incyte set to roll Jakafi – JAK inhibitor into COVID-19
clinical trial Drug manufacturers across the world are rolling already
authorized medicines into late-stage clinical trials in an initiative
to find a quick therapy for COVID-19. Now, 2 more drugs are entering
into late-stage clinical trials, with Swiss drug manufacturers
Novartis and Incyte […]
The post Novartis & Incyte Set To Roll Jakafi – JAK Inhibitor Into
COVID-19 Clinical Trial appeared first on Rasayanika .
https://www.rasayanika.com/2020/04/07/novartis-and-incyte-to-use-jakafi-against-covid-19/
News
Subscribe to:
Post Comments (Atom)
Post a Comment